retatrutide fda approval status november 2025 Is Approved? Current (2026) This weight-loss drug hasn't been

Slows down gastric emptying: Gastric emptying refers to the rate that food moves from the stomach and into the small intestine

It promotes lipolysis (the breakdown of stored fats) and significantly improves mitochondrial function within the liver

Risk of serious side effects such as thyroid cancer, kidney problems, pancreatitis, gallbladder issues, and more, if you take semaglutide without a proper medical evaluation (health history and exam)

BBB, Blood-Brain Barrier

Participants receiving the highest dose of retatrutide experienced a mean weight loss of 24.2% of their body weight, equivalent to about 58 pounds [R]